Filing Flows › GE HealthCare Technologies (GEHC) › Q2 2026 › vs Q2 2025
GE HealthCare Technologies (GEHC) Q2 2026 vs Q2 2025 (year over year)
GE HealthCare Technologies's revenue rose $288M (+6%) from $5.0B in Q2 2025 to $5.3B in Q2 2026. The biggest changes: Product +$153M (+5%); Service +$135M (+8%). Gross margin 41.2% against 39.6% (+1.5 pts).
GE HealthCare Technologies, Q2 2026: revenue $5.3B (+6% year over year), operating margin 14.0%, net earnings $561M, operating cash flow $168M. The chart draws each line against Q2 2025, the increases inside each band.
Margins
| Q2 2026 | Q2 2025 | Change | |
|---|---|---|---|
| Gross margin | 41.2% | 39.6% | +1.5 pts |
| Operating margin | 14.0% | 13.1% | +0.9 pts |
| Net margin | 10.6% | 9.7% | +0.9 pts |
| Free cash flow margin | 1.3% | 0.2% | +1.1 pts |
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Product | $3.4B | $3.3B | $153M | +5% |
| Service | $1.9B | $1.7B | $135M | +8% |
| Revenue | $5.3B | $5.0B | $288M | +6% |
| Gross profit | $2.2B | $2.0B | $195M | +10% |
| Cost of revenue | $3.1B | $3.0B | $93.0M | +3% |
| Operating profit | $739M | $654M | $85.0M | +13% |
| Operating expenses | $1.4B | $1.3B | $110M | +8% |
| Pre-tax earnings | $693M | $613M | $80.0M | +13% |
| Other expense, net | $46.0M | $41.0M | $5.0M | +12% |
| Research & development | $323M | $302M | $21.0M | +7% |
| SG&A | $1.1B | $1.0B | $89.0M | +9% |
| Net earnings | $561M | $486M | $75.0M | +15% |
| Minority interests | $12.0M | $14.0M | −$2.0M | -14% |
| Income tax | $119M | $113M | $6.0M | +5% |
| Operating cash sources | $766M | $668M | $98.0M | +15% |
| Depreciation & amortization | $160M | $148M | $12.0M | +8% |
| Share-based compensation | $45.0M | $34.0M | $11.0M | +32% |
| Working capital & other | $598M | $574M | $24.0M | +4% |
| Operating cash flow | $168M | $94.0M | $74.0M | +79% |
| Free cash flow (OCF − capex) | $68.0M | $8.0M | $60.0M | +750% |
| Capital expenditures | $100M | $86.0M | $14.0M | +16% |
Questions
How much did GE HealthCare Technologies's revenue grow year over year in Q2 2026?
GE HealthCare Technologies's revenue rose $288M (+6%) from $5.0B in Q2 2025 to $5.3B in Q2 2026.
What drove GE HealthCare Technologies's revenue change in Q2 2026?
Product +$153M (+5%); Service +$135M (+8%).